‘We don't want this:' Conway leaders mulling future of planned workforce housing development
'We love our neighborhood. We don't want this,' Chicora Boulevard resident Elizabeth Orlando told the city's planning commission March 6. 'We really don't need more low-income housing for other people who aren't from here to make money from. We need to take care of the residents of the city of Conway.'
On Monday, the city council responded — delaying a rezone vote that would clear the way for North Carolina-based Taft Mills Group to create 80 workforce housing units on 7.8 acres fronting Highway 701.
Officials said they support TMG's concept, but want to find a more suitable spot.
'I would vote 'no' to rezone it, but I would look forward to working with the developer to find a different location that everything would match up better,' councilwoman Julie Hardwick said.
Nate Broman-Fulks, TMG's vice president of development, said the firm would need to have the rezone complete by May 19 in order to apply for tax credit financing through SC Housing.
Conway, he said, makes sense for the project — which would be open to people who make 70% of the area's median income, or $55,500 for a family of four. The multi-story buildings would offer units with up to three bedrooms.
'It's an incredible location near grocery stores and several parks, shopping centers and doctors downtown as well as schools, so it checks all those boxes for us,' Broman-Fulks said March 6.
If approved, the development would be Conway's first tax-credit funded workforce housing project in nearly 20 years and come at a time when average rents in the city are $1,850.
'It's a vibrant community. A lot of people want to be here, so I don't see that going the other direction,' Broman-Fulks said. 'It's probably going to get harder for people to afford to live here that are working here.'
Residents like Kimberley Daley said adding more traffic and people into the area would create public safety issues.
'It all looks wonderful on paper but for everything good about it, there's 100 things bad,' she said March 6.
At least one prominent community group is backing TMG's efforts.
'Affordable housing provides individuals and families with secure, stable homes. This stability is essential for emotional well-being and overall health. Housing is needed much more than another commercial center. Rezoning this parcel will allow the City to meet the crucial need for housing,' Tara Ostrander of the Family Justice Center of Horry and Georgetown Counties wrote in a letter of support.
* * *
Adam Benson joined the News13 digital team in January 2024. He is a veteran South Carolina reporter with previous stops at the Greenwood Index-Journal, Post & Courier and The Sun News in Myrtle Beach. Adam is a Boston native and University of Utah graduate. Follow Adam on X, formerly Twitter, at @AdamNewshound12. See more of his work here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
Lawmakers Press FDA to Target Knockoff Weight-Loss Drugs
(Bloomberg) -- Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks. Trump Awards $1.26 Billion Contract to Build Biggest Immigrant Detention Center in US The High Costs of Trump's 'Big Beautiful' New Car Loan Deduction Can This Bridge Ease the Troubled US-Canadian Relationship? Salt Lake City Turns Winter Olympic Bid Into Statewide Bond Boom Trump Administration Sues NYC Over Sanctuary City Policy On Friday, a group of more than 80 bipartisan lawmakers asked the US Food and Drug Administration to stop counterfeit and copycat versions of GLP-1 drugs like Wegovy and Zepbound from flooding the market — a problem that emerged over the last year. 'We are concerned about recent reports revealing a surge in illegal and counterfeit anti-obesity medications,' they wrote in a letter to FDA Commissioner Marty Makary. 'Undoubtedly, illegal counterfeit medications pose an increased risk to patient safety with sometimes fatal consequences.' The group — spearheaded by Representatives Richard Hudson of North Carolina and Herb Conaway of New Jersey — asked the agency to ramp up enforcement over illegally imported weight-loss drugs. They suggested issuing warning letters and better monitoring non-compliant online retailers and so-called compounding pharmacies that sell the medicines. The lawmakers also said the FDA should work in tandem with US Customs and Border Patrol agents to stop Chinese entities from shipping unsafe weight-loss drugs into the US. They requested an update on the FDA's efforts by July 30, given the 'urgency' of the situation. A spokesperson for the FDA said the agency will work with the US Department of Health and Human Services to provide a 'complete and thorough' response to the issues raised in the lawmakers' letter. 'Any effort to undermine America's supply of safe medicines is an issue that FDA takes seriously,' the spokesperson said. 'And we are deeply committed to strengthening the oversight of imported products at US ports of entry.' In recent years, the popularity of GLP-1 drugs has led to an explosion of copycats and counterfeits made by companies seeking to capitalize on the hype. State-licensed pharmacies were temporarily allowed to make copies of the drugs during a supply shortage, but are no longer permitted to do so after Novo Nordisk A/S and Eli Lilly & Co. boosted production. Still, some pharmacies have refused to wind down their operations while others have pivoted to selling the drugs in lower doses in order to avoid regulatory scrutiny. Counterfeit drugs are made by unregistered entities typically using illegally imported ingredients. As recently as April, there continue to be instances when counterfeit Ozempic pens covertly enter the drug supply chain undetected. Some patients are also purchasing ingredients directly from online sellers in an attempt to make the drugs themselves at home. In both cases, the medications don't go through the same rigorous approval process as brand-name drugs made by Novo and Lilly. Experts worry the lack of oversight is putting patients at risk. The FDA has said it's aware of hospitalizations potentially linked to the copycat drugs, but that adverse events are likely being underreported. 'We support the bi-partisan call for the FDA to crack down on counterfeit and illegally sold weight-loss drugs,' said a spokesperson for Hims & Hers Health Inc., one of the telehealth firms that sells compounded GLP-1s. 'We appreciate lawmakers' recognition that legitimate compounded medications dispensed by state-regulated pharmacies are not counterfeit. Patient safety must always come first.' Novo and Lilly have discouraged consumers from using compounded and counterfeit products, including suing telehealth firms that sell the copycat versions and working with border agents to seize illegal shipments. Under the Biden administration, the companies repeatedly urged the FDA to take action, but the agency mostly limited its actions to issuing consumer warnings — even as its top drug official publicly acknowledged safety concerns. Under the Trump administration, the HHS has also focused more heavily on other issues, such as banning food dyes and examining vaccine schedules. Meanwhile, lawmakers are ramping up their calls for action. State attorneys and other lawmakers have sent letters to the FDA and Federal Trade Commission advocating for greater transparency around the treatments and more scrutiny around marketing practices. (Updates with statement from FDA in sixth and seventh paragraphs.) Burning Man Is Burning Through Cash Confessions of a Laptop Farmer: How an American Helped North Korea's Wild Remote Worker Scheme It's Not Just Tokyo and Kyoto: Tourists Descend on Rural Japan Elon Musk's Empire Is Creaking Under the Strain of Elon Musk A Rebel Army Is Building a Rare-Earth Empire on China's Border ©2025 Bloomberg L.P. Sign in to access your portfolio
The Hill
2 minutes ago
- The Hill
Crypto lobby gains ground under Trump
At least 27 crypto companies or advocates filed their first-ever lobbying disclosures this year across some 20 firms, reflecting an increasing appetite for influence in a more crypto-friendly Washington. The newcomers originate from all corners of the industry. There's betting website Polymarket, a gaming company that created an NFT version of the White House Easter egg hunt, and a Seychelles-based exchange that cannot operate in the U.S. market due to a federal money laundering settlement. Together, they spent nearly $2.8 million between April 1 and June 30 on lobbying landmark legislation promoting digital assets to the Treasury Department and the Securities and Exchange Commission, and a host of other issues relevant to blockchain infrastructure — an increasingly sprawling ecosystem that some hope could one day be as ubiquitous as the internet. The push has paid off for crypto so far. The GENIUS Act, a bill with bipartisan support signed by President Trump last week, has been regarded as the government's 'seal of approval' on the industry. The law sets up a regulatory framework for stablecoins, a type of cryptocurrency that is theoretically pegged to the U.S. dollar or another reference asset. The House also advanced several other landmark bills during its monumental 'crypto week,' which featured high-profile lobbying stunts such as vending machines around the Capitol and the National Mall with customized chocolate bars urging 'yes' votes, bankrolled by the crypto exchange Coinbase. Lobbying expenses that week were not covered in the second quarter disclosures. At least 73 companies or associations focused on crypto disclosed federal lobbying activities, to the tune of about $11.4 million. This total doesn't include spending from investment firms such as Andreessen Horowitz ($790,000) or BlackRock ($810,000) that have substantial crypto interests but also lobbied on a suite of other financial regulation issues. The Hill's Miriam Waldvogel has more here.
Yahoo
31 minutes ago
- Yahoo
Leap Local Launches Map Pack SEO Service to Help Small Businesses Rank Higher on Google Maps
Greensboro, NC, July 25, 2025 (GLOBE NEWSWIRE) -- Leap Local, a digital marketing company dedicated to supporting local businesses, has launched its new Map Pack SEO service. The service is designed to improve visibility in Google's Local 3-Pack, helping businesses attract more customers without relying on paid ads. The Map Pack SEO service includes two flexible plans—Starter and Pro—based on the competition level in a business's local area. Both plans focus on Google Business Profile optimization, high-impact local SEO, and automated strategies that use AI to boost ranking and engagement. 'We created this for businesses that want real results from local search,' said Zack Ellington, founder of Leap Local. 'We're focused on practical SEO that gets more calls and visits—without the need for a big budget.' Plan Highlights Include: Optimization of 1 Google Business Profile Tracking up to 10 geo-grid keywords with Leap Local's Local Rank Tracker 350+ citations across local directories Simulated activity to improve profile engagement AI-powered automation tools Monthly reporting and strategy updates The Starter plan is built for businesses in less competitive spaces—like family dentists, florists, cleaners, and cafes—while the Pro plan is ideal for saturated markets including roofers, med spas, HVAC, and attorneys. To learn more or request a free Local Rank Tracker scan, visit . About Leap Local Leap Local helps small businesses improve their visibility on Google Maps and local search. We use AI and automation to streamline local SEO, optimize your Google Business Profile, and track rankings across nearby areas. Our goal is to help local businesses scale their operations and make it easier for nearby customers to find and contact them—without relying on ads. Press inquiries Leap Local Zack Ellington zack@
